Stéphane Bancel joined Moderna in the summer of 2011 when it was a one-employee company. He has assembled a world-class team and raised nearly $2 billion between equity financing and upfront from licensing collaborations.
Previously, Mr. Bancel was CEO of bioMérieux, a leading diagnostics company. Prior to bioMérieux, he was the managing director of Eli Lilly Belgium and executive director of global manufacturing strategy and supply chain at Eli Lilly in Indianapolis, Indiana.
He holds a Master of Engineering from École Central Paris, a Master of Science in Chemical Engineering from the University of Minnesota and an MBA from Harvard Business School.